>

>

Indication prioritization for platform technology

Service Areas
Therapeutic Areas

Central Nervous System

Client Type

Mid-size Biotech

Client Problems

  • Our client, a mid-size biotech company, has a platform technology to cross the blood brain barrier and deliver a novel therapeutic modality


  • The client wanted to first identify indications with an unmet need that would benefit from the novel therapeutic modality


  • The client then wanted to build a framework for prioritizing indications, and to create a commercialization strategy for each prioritized indication

What We Did

  • Developed an indication selection and prioritization scheme for the platform technology


  • Prioritized the top 5 indications based on preclinical and clinical feasibility and commercialization potential


  • Assessed the clinical trial and competitor landscape for each indication


  • Created R&D and commercialization strategies for prioritized indications

Our Results And Insight

  • Comprehensive indication selection schema


  • Current clinical trial assessment of competitors for top prioritized indication


  • Top 5 prioritized indications based on technical feasibility of MOA, unmet needs, competitive landscape


  • Overview of R&D and commercialization strategy

See other case studies

Commercial Strategy case studies >

Central Nervous System case studies >

Service Areas Details

Commercial Strategy (Indication Assessment)

Therapeutic Areas Details

Central Nervous System (Alzheimer's)

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net